Loading clinical trials...
Loading clinical trials...
The main purpose of this study is to evaluate the safety, tolerability of LY4086940 and how it is processed in the body. Participation in Part A of the study will last about 10 weeks and may include ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
1-317-615-4559LillyTrials@Lilly.comPhysicians interested in becoming principal investigators please contact
CONTACT
clinical_inquiry_hub@lilly.comLead Sponsor
Eli Lilly and Company
NCT06631261 · Bronchiectasis Adult, Healthy Controls Group - Age and Sex-matched
NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss
NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more
NCT07595549 · Obesity, Overweight and/or Obesity, and more
NCT06937086 · Ulcerative Colitis, Obesity or Overweight
Fortrea Clinical Research Unit
Daytona Beach, Florida
Clinical Pharmacology of Miami
Miami, Florida
Fortrea Clinical Research Unit
Dallas, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions